Category: Peptide Q&A

What is the risk of immune reaction or antibody development against exogenous kisspeptin?

What evidence exists for kisspeptin’s role in modulating cognitive function, memory, and neuroplasticity in animal models?

What is the strength of clinical evidence supporting kisspeptin as a first-line treatment for infertility compared to standard protocols?

What are the limitations of current clinical trials on kisspeptin, such as small sample sizes or short follow-up periods?

Does kisspeptin influence sleep-wake cycles or circadian rhythms, and what is the underlying neuroanatomical basis?

How do randomized controlled trials (RCTs) compare kisspeptin to recombinant FSH in terms of live birth rates and ovarian response?

How does kisspeptin interact with metabolic regulators such as leptin and insulin to influence energy homeostasis?

What meta-analyses or systematic reviews summarize the efficacy and safety of kisspeptin in reproductive medicine?

What is the role of kisspeptin in regulating body weight and adiposity, particularly in states of energy deficit or obesity?

How does kisspeptin compare to pulsatile GnRH therapy in restoring fertility in patients with hypothalamic amenorrhea?